4 Results for "

HDAC2-IN-1

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "HDAC2-IN-1" in MCE Product Catalog:

Cat. No.: HY-151248
CAS No.: 2919691-32-8
Target:  

HDAC

Research Areas:  

Neurological Disease

HDAC2-IN-1 (Compound 17) is a brain penetrant, orally active, competitive HDAC2 inhibitor with an IC50 of 0.5 μM . HDAC2-IN-1 also inhibits HDAC1 and HDAC8 with IC50s of 1.61 μM and 0.98 μM, respectively .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-18700
CAS No.: 1440209-96-0
Target:  

HDAC

Research Areas:  

Cancer

BRD73954 is a potent HDAC inhibitor and selectively inhibiting both HDAC6 and HDAC8 with IC50 values of 0.0036, 0.12, 9, 12, 23 µM for HDAC6, HDAC8, HDAC2, HDAC1 and HDAC3, respectively. BRD73954 decreases the levels of HDAC6, associated with upregulation of Ac-Tubulin .
loading...
    loading...
Cat. No.: HY-157388
CAS No.: 3074558-69-0
Purity:  95.17%
Research Areas:  

Cancer

CARM1/HDAC2-IN-1 (compound CH-1) is a dual inhibitor against CARM1 and HDAC2, with IC50 values of 3.71 nM and 4.07 nM, respectively. CARM1/HDAC2-IN-1 possesses antitumor activity .
loading...
    loading...
Cat. No.: HY-162769
CAS No.: 3095232-95-1
Target:  

HDAC Apoptosis

Research Areas:  

Cancer

HDAC3-IN-5 (9c) is a HDAC3 selective inhibitor, with IC50 values of 4.2 nM, 1629 nM and 298.2 nM for HDAC3, HDAC2, HDAC1, respectively. HDAC3-IN-5 (9c) can effectively induce apoptosisin MV4-11 cells in vitro and reduce the expression of anti-apoptotic proteins, the development of HDAC3 selective inhibitors may serve as a potential lead compound to reverse Venetoclax resistance .
loading...
    loading...